GOSS earnings date and last-quarter result: last quarter miss, P/E -0.18. Updated 2026-07-23.
Gossamer Bio (GOSS) Research Hub
Gossamer Bio (GOSS) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.15 USD (-4.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.18, market cap 0.03B. This hub links to the full technical, earnings and options research available for GOSS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.15 USD (-4.74%) |
| 52-week range | 0.127 USD – 12.54 USD |
| Trend regime | Range |
| 14-day RSI | 35.4 (Bearish) |
| Trailing P/E | -0.18 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
Available research for GOSS
Covered Call on GOSS: how it works, illustrative setup around the real 9.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GOSS: how it works, illustrative setup around the real 9.15 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GOSS: how it works, illustrative setup around the real 9.15 USD price, max profit/loss, breakeven and when to use it. Educational.
GOSS technical analysis: range, last 9.15 USD, RSI 35.4, 52w range 0.127 USD–12.54 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GOSS in?
Gossamer Bio (GOSS) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GOSS in an uptrend or downtrend?
As of 2026-10-26, GOSS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GOSS's trailing P/E ratio?
GOSS's trailing P/E is -0.18, with a market cap of 0.03B. See the earnings research page for full valuation detail.